Back to News
investment

Intersection Of Biosecurity And AI Sees Seed-Stage Spike

Joanna Glasner
Loading...
5 min read
0 likes
⚡ Quantum Brief
Two AI-biosecurity startups—Valthos ($30M) and Red Queen Bio ($15M)—secured seed funding in late 2025, with OpenAI as a key investor. Both focus on countering AI-driven biological threats, signaling growing venture interest in this high-stakes niche. OpenAI’s involvement highlights the urgency of AI-accelerated biosecurity risks, as advanced models could weaponize pathogens faster than defenses can adapt. Startups argue AI’s exponential growth demands equally scalable countermeasures. Nonprofit SecureBio received $1.4M in grants to prevent catastrophic pandemics, underscoring parallel efforts beyond for-profit ventures. The sector remains underfunded relative to broader AI investments like OpenAI’s $110B round. Historically, biosecurity startups targeted livestock (e.g., ExoFlare, Daro), but AI integration marks a shift toward human-centric threat detection and mitigation, a nascent but critical frontier. Experts warn AI could outpace biological defense systems, with Valthos and Red Queen Bio framing the challenge as an evolutionary arms race—where falling behind risks existential consequences.
AI Audio Summary
0:00 / 0:00
Click to play
pexels-iohichu-34924856.jpg
Quantum News · Media Library

Joanna Glasner jglasner 0 Shares Email Facebook Twitter LinkedIn There are plenty of things to worry about these days, and the ability of AI to weaponize biology into one of the largest threats facing our world isn’t top of mind for most of us. Seed-stage investors have a different view. Over the past few months, two startups focused on the intersection of AI and biosecurity have raised good-sized initial rounds with OpenAI among their investors. Valthos, a developer of AI systems that identify biological threats and design countermeasures, raised $30 million last fall in its first known funding round.

The New York-headquartered company counts Founders Fund and Lux Capital as backers, along with OpenAI. Weeks later, Red Queen Bio, a self-described AI biosecurity company, secured $15 million in a seed round led by OpenAI and joined by investors including Cerberus Ventures, Fifty Years and Halcyon Futures. The company’s operating thesis is that as AI capabilities advance, biological risks grow exponentially, so defenses must scale at the same rate. On the nonprofit front, meanwhile, Cambridge, Massachusetts-based SecureBio secured grant funding from multiple sources last year, including $1.4 million from Coefficient Giving in December. The organization’s stated mission is to secure the future from catastrophic pandemics. A drop in the AI bucket Given all the capital that has poured into artificial intelligence of late, these are not comparatively large sums going to biosecurity. To put it in perspective, the two biggest seed rounds are less than one-tenth of a percent of the record-setting $110 billion financing OpenAI secured last week. What’s more noteworthy than sums invested is these are relatively new areas for startups to scale. Per Crunchbase data, the term “biosecurity” and similar terminology has cropped up in funded startup descriptions but not so much in the context of AI. Funded startups around this theme have also commonly focused on livestock. The Australian startup ExoFlare, for instance, raised a few million two years ago, per Crunchbase data, with a focus on tracking biosecurity risks for cattle, pigs, eggs and poultry. And Nebraska-based Daro picked up $1.1 million last year for a business focused on swine disease surveillance. Running in place In addition to their AI focus, the latest crop of biosecurity seed-funded startups stand out for the dire scenarios they’re hoping to contain. Per Valthos, it’s now faster to weaponize biology than to advance new cures, an ominous development that AI leaders have identified as one of the largest threats of our time. The company envisions a future where any threat to human health can be immediately identified and neutralized.

Red Queen Bio evokes a similarly alarming specter of threats, reflected in its nomenclature.

The Red Queen hypothesis, a notion that evolution requires constant adaptation to ever-evolving threats, stems from a “Through the Looking Glass” passage. In it, the tyrannical Red Queen explains that in her kingdom, “it takes all the running you can do, to keep in the same place.” Running to keep in the same place seems a more broadly apt metaphor for the modern era in myriad domains, not just biosecurity. However, this is one of the spaces where not keeping up carries the potentially deadliest penalties. Illustration: Dom Guzman Tagsagriculture AI seed funding startups unicorn venture Stay up to date with recent funding rounds, acquisitions, and more with the Crunchbase Daily. You may also like Artificial intelligence • Robotics • Seed funding • Semiconductors and 5G • Startups • Transportation & Logistics • Venture Massive AI Deals Drive $189B Startup Funding Record In February While Public Software Stocks Reel Gené TeareMarch 3, 2026 Crunchbase data shows global venture investment totaled $189 billion in February — the largest startup funding month on record — although 83% of... Fintech • SaaS • Startups • Venture • Web3 Over $50B Went To Boom-Era Software Companies That Haven’t Raised In 4+ Years Joanna GlasnerMarch 2, 2026 Four-year funding gaps are top of mind these days, as it’s been that long since U.S. venture investment hit its all-time peak. During the funding... Artificial intelligence • Robotics • Seed funding • Semiconductors and 5G • Startups • Transportation & Logistics • Venture Massive AI Deals Drive $189B Startup Funding Record In February While Public Software Stocks Reel Gené TeareMarch 3, 2026 Crunchbase data shows global venture investment totaled $189 billion in February — the largest startup funding month on record — although 83% of... Fintech • SaaS • Startups • Venture • Web3 Over $50B Went To Boom-Era Software Companies That Haven’t Raised In 4+ Years Joanna GlasnerMarch 2, 2026 Four-year funding gaps are top of mind these days, as it’s been that long since U.S. venture investment hit its all-time peak. During the funding... Artificial intelligence • Crypto • M&A • Regional • Seed funding • Startups • Venture Q1 Global Startup Funding Posts Strongest Quarter Since Q2 2022 With A Third Going To Massive OpenAI Deal April 3, 20257 Min Read

Read Original

Tags

aerospace-defense
quantum-investment
startup

Source Information

Source: Crunchbase News

Discussion

0 professional contributions

Sign in to join this professional discussion.

Be the first to add a constructive contribution.